These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35984927)

  • 1. Effects of Δ
    Iglesias LP; Bedeschi L; Aguiar DC; Asth L; Moreira FA
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):24-33. PubMed ID: 35984927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic nicotine exposure attenuates the effects of Δ
    Manwell LA; Miladinovic T; Raaphorst E; Rana S; Malecki S; Mallet PE
    Brain Behav; 2019 Nov; 9(11):e01375. PubMed ID: 31583843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids, interoception, and anxiety.
    Andrade AK; Renda B; Murray JE
    Pharmacol Biochem Behav; 2019 May; 180():60-73. PubMed ID: 30922834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.
    Rubino T; Guidali C; Vigano D; Realini N; Valenti M; Massi P; Parolaro D
    Neuropharmacology; 2008 Jan; 54(1):151-60. PubMed ID: 17692344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.
    Rey AA; Purrio M; Viveros MP; Lutz B
    Neuropsychopharmacology; 2012 Nov; 37(12):2624-34. PubMed ID: 22850737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
    Hempel B; Xi ZX
    Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?
    Genn RF; Tucci S; Parikh S; File SE
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):93-9. PubMed ID: 15205871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of cannabinoid agents in animals.
    Chaperon F; Thiébot MH
    Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Potential Anxiolytic Effects of Minor Cannabinoids and Terpenes After Acute and Chronic Oral Administration in Rats.
    Jenkins BW; Moore CF; Covey D; McDonald JD; Lefever TW; Bonn-Miller MO; Weerts EM
    Cannabis Cannabinoid Res; 2023 Sep; 8(S1):S11-S24. PubMed ID: 37721993
    [No Abstract]   [Full Text] [Related]  

  • 12. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
    J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
    Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
    Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
    Lile JA; Kelly TH; Hays LR
    Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthetic CB
    Coronado-Álvarez A; Romero-Cordero K; Macías-Triana L; Tatum-Kuri A; Vera-Barrón A; Budde H; Machado S; Yamamoto T; Imperatori C; Murillo-Rodríguez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110301. PubMed ID: 33741446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
    Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
    Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highway to hell or magic smoke? The dose-dependence of Δ
    Kubilius RA; Kaplick PM; Wotjak CT
    Learn Mem; 2018 Sep; 25(9):446-454. PubMed ID: 30115766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Δ
    Darmani NA; Belkacemi L; Zhong W
    Eur J Pharmacol; 2019 Dec; 865():172806. PubMed ID: 31738934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.
    Rodgers RJ; Evans PM; Murphy A
    Behav Pharmacol; 2005 Sep; 16(5-6):405-13. PubMed ID: 16148445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.